Chemopreventive Efficacy of Broccoli Sprouts against BC

西兰花芽对 BC 的化学预防功效

基本信息

  • 批准号:
    7902236
  • 负责人:
  • 金额:
    $ 38.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Epidemiological studies provide convincing evidence for an inverse relation between quantities of fruit and vegetables consumed and the risk of developing cancer. Cruciferous vegetable (e.g., broccoli) consumption has been recently associated with reduced risk for breast cancer. A major mechanism for protection against carcinogenesis involves induction of phase 2 detoxication enzymes that promote elimination of carcinogens and boost antioxidant capacity. Many edible plants, most notably 3-day-old broccoli sprouts, contain potent phase 2 enzyme inducer activity in the form of isothiocyanates or their glucosinolate precursors. In animals, sulforaphane, derived from the principal glucosinolate (glucoraphanin) of broccoli sprouts, is a very potent inducer of phase 2 enzyme activity and protects against chemical carcinogenesis. The objective of this study is to translate and evaluate these laboratory findings in a human population at elevated risk for breast cancer. Previous trials have afforded important information on the safety, metabolism, and urinary disposition of isothiocyanates, and on the activation of glucosinolates. Therefore, our aims are to 1) determine the pharmacodynamic action of a broccoli sprouts preparation, as well as pure sulforaphane and pure glucoraphanin, in the mammary epithelium of rodents to develop better biomarkers; 2) evaluate the pharmacokinetics and pharmacodynamic action of broccoli sprouts in 30 healthy women undergoing breast reduction surgery or prophylactic mastectomy by conducting a 10-day randomized placebo controlled clinical trial that measures isothiocyanate levels in blood, urine and mammary tissue as well as phase 2 inducer activity, mRNA transcript levels and estrogen metabolites in mammary tissue; and 3) test whether a 3 month intervention of a broccoli sprout preparation modulates a panel of breast cancer risk biomarkers (Ki67 expression, estrogen metabolite profiles, novel markers) compared to placebo in 126 women at increased risk for breast cancer using a Phase II randomized clinical trial design. These studies will provide a rigorous assessment of the usefulness of modulating expression of carcinogen detoxication enzymes and other sulforaphane target genes by means of a food containing a standardized level of a phytochemical as a general strategy for chemoprevention in humans
流行病学研究提供了令人信服的证据,证明水果数量和 食用蔬菜和罹患癌症的风险。十字花科蔬菜(如西兰花)消费 最近与降低乳腺癌风险有关。一种主要的防范机制 致癌涉及诱导第二相解毒酶促进致癌物的消除 并增强抗氧化能力。许多可食用植物,尤其是3天大的西兰花芽,都含有强效成分 第二阶段酶以异硫氰酸酯或其硫代葡萄糖苷前体的形式诱导活性。在动物身上, 萝卜硫素,来源于西兰花芽中的主要硫代葡萄糖苷(硫代萝卜素),是一种非常有效的 2相酶活性诱导剂,防止化学致癌。这样做的目的是 这项研究是在乳腺癌高危人群中翻译和评估这些实验室发现。 癌症。以前的试验已经提供了关于安全性、新陈代谢和尿液的重要信息。 异硫氰酸盐的处置,以及硫代葡萄糖苷的活化。因此,我们的目标是1) 测定西兰花芽制剂以及纯萝卜硫素的药效作用 在啮齿动物的乳腺上皮中,开发出更好的生物标志物;2)评估 西兰花芽在30名乳房健康女性体内的药代动力学和药效学作用 通过进行为期10天的随机安慰剂对照临床研究,进行乳房缩小手术或预防性乳房切除术 测量血液、尿液和乳腺组织中异硫氰酸酯水平的试验以及第二阶段诱导剂 乳腺组织的活性、mRNA转录水平和雌激素代谢产物;3)检测3个月后 干预西兰花芽制剂调节一组乳腺癌风险生物标记物(Ki67 表达,雌激素代谢物分布,新的标记物)与安慰剂相比,126名妇女在增加 使用II期随机临床试验设计的乳腺癌风险。这些研究将提供一个严格的 调节致癌物解毒酶和其他基因表达的有效性评估 萝卜硫素靶基因通过含有标准化水平植物化学物质作为 人类化学预防的一般策略

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS A KENSLER其他文献

THOMAS A KENSLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS A KENSLER', 18)}}的其他基金

RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions
研究项目 4:基于生物标志物的人类干预评估
  • 批准号:
    8376305
  • 财政年份:
    2012
  • 资助金额:
    $ 38.44万
  • 项目类别:
RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions
研究项目 4:基于生物标志物的人类干预评估
  • 批准号:
    8278591
  • 财政年份:
    2011
  • 资助金额:
    $ 38.44万
  • 项目类别:
Chemopreventive Efficacy of Broccoli Sprouts against BC
西兰花芽对 BC 的化学预防功效
  • 批准号:
    7212434
  • 财政年份:
    2006
  • 资助金额:
    $ 38.44万
  • 项目类别:
Chemopreventive Efficacy of Broccoli Sprouts against BC
西兰花芽对 BC 的化学预防功效
  • 批准号:
    7726891
  • 财政年份:
  • 资助金额:
    $ 38.44万
  • 项目类别:
RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions
研究项目 4:基于生物标志物的人类干预评估
  • 批准号:
    7849774
  • 财政年份:
  • 资助金额:
    $ 38.44万
  • 项目类别:
Chemopreventive Efficacy of Broccoli Sprouts against BC
西兰花芽对 BC 的化学预防功效
  • 批准号:
    8182378
  • 财政年份:
  • 资助金额:
    $ 38.44万
  • 项目类别:
Chemopreventive Efficacy of Broccoli Sprouts against BC
西兰花芽对 BC 的化学预防功效
  • 批准号:
    7726900
  • 财政年份:
  • 资助金额:
    $ 38.44万
  • 项目类别:
RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions
研究项目 4:基于生物标志物的人类干预评估
  • 批准号:
    7515930
  • 财政年份:
  • 资助金额:
    $ 38.44万
  • 项目类别:
RESEARCH PROJECT 4: Biomarker-based Evaluation of Human Interventions
研究项目 4:基于生物标志物的人类干预评估
  • 批准号:
    8078953
  • 财政年份:
  • 资助金额:
    $ 38.44万
  • 项目类别:

相似海外基金

Determining 4-Dimensional Foot Loading Profiles of Healthy Adults across Activities of Daily Living
确定健康成年人日常生活活动的 4 维足部负荷曲线
  • 批准号:
    2473795
  • 财政年份:
    2024
  • 资助金额:
    $ 38.44万
  • 项目类别:
    Studentship
Developing a trunk function assessment for hemiplegics. -For improving activities of daily living-
开发偏瘫患者的躯干功能评估。
  • 批准号:
    23K10540
  • 财政年份:
    2023
  • 资助金额:
    $ 38.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relation with the activities of daily living and the subjective values among people with social withdrawal
社交退缩者日常生活活动与主观价值观的关系
  • 批准号:
    23K16596
  • 财政年份:
    2023
  • 资助金额:
    $ 38.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CRII: RI: Understanding Activities of Daily Living in Indoor Scenarios
CRII:RI:了解室内场景中的日常生活活动
  • 批准号:
    2245652
  • 财政年份:
    2023
  • 资助金额:
    $ 38.44万
  • 项目类别:
    Standard Grant
Association between Nursing Care and Prognosis and Activities of Daily Living in Acute Stroke patients by using Big Data.
利用大数据研究急性脑卒中患者的护理与预后和日常生活活动的关系。
  • 批准号:
    23K16412
  • 财政年份:
    2023
  • 资助金额:
    $ 38.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Sources of vulnerability among those using homecare despite having no limitations in Activities of Daily Living. An intersectionality analysis
尽管日常生活活动没有限制,但使用家庭护理的人的脆弱性来源。
  • 批准号:
    499112
  • 财政年份:
    2023
  • 资助金额:
    $ 38.44万
  • 项目类别:
    Operating Grants
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
  • 批准号:
    10429480
  • 财政年份:
    2022
  • 资助金额:
    $ 38.44万
  • 项目类别:
Effects of a model of nurses-occupational therapists collaborative practice on activities of daily living in elderly patients
护士-职业治疗师合作实践模式对老年患者日常生活活动的影响
  • 批准号:
    22K17540
  • 财政年份:
    2022
  • 资助金额:
    $ 38.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Assessing a Novel Virtual Environment that Primes Individuals Living with AD/ADRD to Accomplish Activities of Daily Living.
评估一种新颖的虚拟环境,该环境可以帮助 AD/ADRD 患者完成日常生活活动。
  • 批准号:
    10668160
  • 财政年份:
    2022
  • 资助金额:
    $ 38.44万
  • 项目类别:
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
  • 批准号:
    10621820
  • 财政年份:
    2022
  • 资助金额:
    $ 38.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了